As Baidu raced to develop its ChatGPT equivalent, employees working to advance AI technologies for drug discovery had to suspend their research and cede their computer chips to develop the chatbot instead. The current AI paradigm is also choking off alternative paths to AI development. The number of independent researchers not affiliated with or receiving funding from the tech industry has rapidly dwindled, diminishing the diversity of ideas in the field not tied to short-term commercial benefit. Companies themselves, which once invested in sprawling exploratory research, can no longer afford to do so under the weight of the generative AI development bill. Younger generations of scientists are falling in line with the new status quo to make themselves more employable. What was once unprecedented has become the norm.